MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Phenotypic Aspects of Huntington’s Disease-Like 2 in Brazil and the World: Literature Review

    D. Boone, M. Costa, C. Silva, L. Barcelos, B. Veiga, R. Pinto, P. Aguiar, S. Azevedo, V. Borges, H. Ferraz (São Paulo, Brazil)

    Objective: To describe the known phenotypic profile of HDL2 patients currently described in the literature. Background: HDL2 is an autosomal dominant neurodegenerative disorder caused by…
  • 2024 International Congress

    The clinical features, neuroimagings and outcomes of diabetic striatopathy: a retrospective study at tertiary hospital in Vietnam

    T. Nguyen, N. Nguyen, K. Le, K. Nguyen, T. Tran (Ho Chi Minh, Viet Nam)

    Objective: This study aims to analyze the clinical features, neuroimaging findings, and outcomes of diabetic striatopathy among Vietnamese patients. Background: Diabetic striatopathy (DS) is a…
  • 2024 International Congress

    Choreiform Movements Secondary to Sarcoidosis Without Central Nervous System Granulomatosis

    O. Carranza-Renteria, T. Hammond (Boca Raton, USA)

    Objective: To share our experience managing a patient who presented with choreiform movements found to be secondary to sarcoidosis without CNS Granulomatosis. Background: Sarcoidosis is…
  • 2024 International Congress

    Ektacytometry in Neuroacanthocytosis

    M. Paucar, C. Rubin, J. Wincent, S. Hertegård, R. Möller, S. Beshara, P. Svenningsson (Stockholm, Sweden)

    Objective: Here we report two patients with genetically confirmed neuroacanthocytosis (NA) and expand the role of ektacytometry for the assessment of acanthocytes. Background: The main…
  • 2024 International Congress

    Volatile solvent abuse and Cerebellar ataxia: A case series

    J. Ganguly, S. Jha, N. Pandita, S. Mukherjee, N. Singh, H. Kumar (Kolkata, India)

    Objective: Delineation of clinical and radiological features of cerebellar ataxia from volatile solvent abuse. Background: Volatile solvents like glues, correction fluid, acrylic paints, varnishes, lacquers…
  • 2024 International Congress

    CAPRIN1 defect: a new severe neurodegenerative disorder with childhood dementia, myoclonus-ataxia, and sensorimotor neuropathy

    R. Bove, A. Torella, G. Ricciardi, L. Pollini, M. Novelli, F. Pisani, V. Nigro, V. Leuzzi, S. Galosi (Rome, Italy)

    Objective: To present the case of a patient with a severe neurodegenerative disorder with onset in pediatric age carrying a pathogenic variant in CAPRIN1 gene…
  • 2024 International Congress

    Mixed Cerebellar Ataxia in a Patient with a Novel FAT2 Gene Variant Associated with SCA45

    A. Richmond, M. Nashatizadeh, R. Townley (Columbia, USA)

    Objective: We describe a patient with late-onset ataxia, cognitive impairment, and parkinsonism with a novel missense variant in FAT2, a gene implicated in spinocerebellar ataxia…
  • 2024 International Congress

    A Scoping Review of Epidural Spinal Cord Stimulation in the Treatment of Multiple Movement Disorder Symptoms

    D. Megan, J. Kramer, L. Venkatesan (Harrogate, United Kingdom)

    Objective: Conduct a scoping review to examine the effects of epidural spinal cord stimulation on multiple clinical symptoms of movement disorders. Background: Prior research has…
  • 2024 International Congress

    Alterations in neural processes of cognitive control in asymptomatic heterozygous mutation carriers in the Parkin gene

    J. Böhm, J. Uter, R. Lundin, J. Henkel, P. Pramstaller, C. Klein, A. Hicks, M. Heldmann, N. Brüggemann (Lübeck, Germany)

    Objective: Investigating heterozygous Parkin gene (PRKN) mutation carriers to evaluate the potential association of this mutation with an alteration of cognitive control processes. Background: Recessively…
  • 2024 International Congress

    Combining Carbidopa/levodopa Extended-release Capsules and Immediate-release Tablets – Crucial Factors of This Economical Prescription

    Y. Tai, S. Hsu, H. Kuo (Kaohsiung City, Taiwan)

    Objective: We introduced a new way of prescribing carbidopa/levodopa extended-release (ER) capsule – combining use of immediate-release (IR) tablets. This retrospective clinical study was designed…
  • « Previous Page
  • 1
  • …
  • 462
  • 463
  • 464
  • 465
  • 466
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley